C57BL/6JCya-Ttrem1/Cya
Common Name:
Ttr-KO
Product ID:
S-KO-05588
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ttr-KO
Strain ID
KOCMP-22139-Ttr-B6J-VA
Gene Name
Product ID
S-KO-05588
Gene Alias
prealbumin
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
18
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ttrem1/Cya mice (Catalog S-KO-05588) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000075312
NCBI RefSeq
NM_013697.5
Target Region
Exon 2
Size of Effective Region
~0.3 kb
Detailed Document
Overview of Gene Research
Transthyretin (TTR) is one of the major amyloidogenic proteins in systemic amyloidosis. It forms extracellular amyloid deposits in systemic organs like nerves, ligaments, heart, and arterioles, causing two types of systemic amyloidosis: hereditary ATTR (ATTRv) amyloidosis induced by variant TTR and aging-related wild-type ATTR (ATTRwt) amyloidosis [1]. TTR is also involved in maintaining cellular proteostasis, as it can respond to excessive TARDBP (associated with neurological disorders) by promoting autophagy and facilitating the degradation of aggregated TARDBP [3].
Mutations in the TTR gene are associated with Familial amyloidotic polyneuropathy (FAP). Transgenic mouse models, such as the TTR exon-humanized mouse, have been developed to study FAP. These models help in understanding the disease mechanism and testing new therapies [2]. In the HSF ± hTTR V30M mouse model, which expresses human TTRV30M in a Ttr null background, studies on TTR deposition in the heart have provided insights into the cellular environment of TTR deposits in ATTR-Cardiomyopathy, potentially leading to new therapeutic strategies [4].
In conclusion, TTR is crucial in the context of systemic amyloidosis and neurological disorders. Mouse models, especially those with modified TTR genes, have significantly contributed to understanding the role of TTR in diseases like FAP and ATTR-Cardiomyopathy, enabling the development of new treatment strategies for these conditions.
References:
1. Ueda, Mitsuharu. 2022. Transthyretin: Its function and amyloid formation. In Neurochemistry international, 155, 105313. doi:10.1016/j.neuint.2022.105313. https://pubmed.ncbi.nlm.nih.gov/35218869/
2. Li, Zhenghua, Kanazashi, Hideki, Tokashiki, Yoshimi, Chen, Hong, Yamamura, Kenichi. 2022. TTR exon-humanized mouse optimal for verifying new therapies for FAP. In Biochemical and biophysical research communications, 599, 69-74. doi:10.1016/j.bbrc.2022.02.035. https://pubmed.ncbi.nlm.nih.gov/35176627/
3. Chu, Yuan-Ping, Ho, Pei-Chuan, Tsai, Kuen-Jer. 2023. TTR (transthyretin) leads the autophagy disaster relief team against TARDBP/TDP-43 proteinopathy. In Autophagy, 19, 2403-2405. doi:10.1080/15548627.2023.2167690. https://pubmed.ncbi.nlm.nih.gov/36633448/
4. Teixeira, Cristina, Martins, Helena Sofia, Saraiva, Maria João. 2023. Cellular environment of TTR deposits in an animal model of ATTR-Cardiomyopathy. In Frontiers in molecular biosciences, 10, 1144049. doi:10.3389/fmolb.2023.1144049. https://pubmed.ncbi.nlm.nih.gov/36968272/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen